Under the terms of the collaboration, Unilife has granted Amgen exclusive rights to Unilife's wearable injectors within select drug classes for use with certain Amgen assets, while preserving rights previously granted to other Unilife customers
The esclusivity is not for all W.I.S but in certain classes of drugs, so for instance Sanofi will continue with their contract . Whether Amgen got all other areas or just some we do not know
- Forums
- ASX - By Stock
- Unis short sale restriction
Under the terms of the collaboration, Unilife has granted Amgen...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm